The Exponent Inc (EXPO) share price is expected to increase by 15.14% over the next year. This is based on calculating the average 12-month share price estimate provided by 2 stock analysts who have covered EXPO. Price targets range from $82.00 at the low end to $95.00 at the high end. The current analyst consensus for EXPO is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Exponent Inc has a total of 2 Wall St Analyst ratings. There are 1 buy ratings, 1 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Exponent Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
joshua chan UBS | Hold | $82.0 | maintained | Feb 4, 2024 |
tobey sommer Truist Financial | Buy | $95.0 | maintained | Feb 2, 2024 |
alexander leach Berenberg Bank | Buy | $116.0 | maintained | May 7, 2022 |
sam england Berenberg Bank | Buy | $135.0 | maintained | Oct 8, 2021 |
marc riddick Sidoti | Buy | $105.0 | maintained | Jul 31, 2020 |
timothy mchugh William Blair | Hold | None | reiterated | Sep 13, 2018 |
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
When did it IPO
0
Staff Count
1,050
Country
United States
Sector/Industry
Industrials/Engineering & Construction
CEO
Dr. Catherine Ford Corrigan P.E., Ph.D.
Market Cap
$3.91B
In 2023, EXPO generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that EXPO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
PGNY-USD
$40.78
LOPE-USD
$130.07
AXSM-USD
$80.47
LNTH-USD
$57.46
COLB-USD
$18.28
NEOG-USD
$17.64